Nayan Madhur, Hamilton Robert J, Finelli Antonio, Austin Peter C, Kulkarni Girish S, Juurlink David N
Division of Urology, Departments of Surgery and Surgical Oncology, Princess Margaret Cancer Centre, University Health Network and the University of Toronto, Toronto, ON, Canada.
Institute for Clinical Evaluative Sciences, University of Toronto, Toronto, ON, Canada.
Can Urol Assoc J. 2017 Jun;11(6):167-171. doi: 10.5489/cuaj.4569.
Variables, such as smoking and obesity, are rarely available in administrative databases. We explored the added value of including these data in an administrative database study evaluating the association of statin use with survival in kidney cancer.
We linked administrative data with chart-abstracted data on smoking and obesity for 808 patients undergoing nephrectomy for kidney cancer. Base models consisted of variables from administrative databases (age, sex, year of surgery, and different measures of comorbidity [to compare their sensitivity to smoking and obesity data]); extended models added chart-abstracted data. We compared coefficients for statin use with overall (OS) and cancer-specific survival (CSS), and used the c-statistic and net reclassification improvement (NRI) to compare predications of five-year survival obtained from Cox proportional hazard models.
The coefficient for statin use changed minimally following addition of abstracted data (<6% for OS, <2% for CSS). Base models performed similarly for OS, with c-statistics of 0.75 (95% confidence interval [CI] 0.72-0.79) for Charlson score and 0.73 (95% CI 0.69-0.78) for John Hopkins Aggregated Diagnosis Groups score. After including abstracted data, c-statistics modestly improved (change <0.02); CSS demonstrated similar findings. NRIs were 0.210 (95% CI 0.062-0.297) and 0.186 (-0.031-0.387) when using the Charlson score, and 0.207 (0.068-0.287) and 0.197 (0.007-0.399) when using the Aggregated Diagnosis Groups score, for OS and CSS, respectively.
The inclusion of data on smoking and obesity marginally influences survival models in kidney cancer studies using administrative data.
吸烟和肥胖等变量在行政数据库中很少能获取到。我们探讨了在一项评估他汀类药物使用与肾癌生存率之间关联的行政数据库研究中纳入这些数据的附加价值。
我们将行政数据与808例接受肾癌肾切除术患者的吸烟和肥胖的病历摘要数据相链接。基础模型由行政数据库中的变量组成(年龄、性别、手术年份以及不同的合并症测量指标[以比较它们对吸烟和肥胖数据的敏感性]);扩展模型增加了病历摘要数据。我们比较了他汀类药物使用与总生存期(OS)和癌症特异性生存期(CSS)的系数,并使用c统计量和净重新分类改善(NRI)来比较从Cox比例风险模型获得的五年生存期预测。
添加摘要数据后,他汀类药物使用的系数变化极小(OS变化<6%,CSS变化<2%)。基础模型在OS方面表现相似,Charlson评分的c统计量为0.75(95%置信区间[CI]0.72 - 0.79),约翰霍普金斯综合诊断组评分的c统计量为0.73(95%CI 0.69 - 0.78)。纳入摘要数据后,c统计量略有改善(变化<0.02);CSS显示出类似结果。使用Charlson评分时,OS和CSS的NRI分别为0.210(95%CI 0.062 - 0.297)和0.186(-0.031 - 0.387),使用综合诊断组评分时,OS和CSS的NRI分别为0.207(0.068 - 0.287)和0.197(0.007 - 0.399)。
在使用行政数据的肾癌研究中,纳入吸烟和肥胖数据对生存模型的影响微乎其微。